ChartRow logo
Data provided bySource: Twelve Data
RPRX
$68.68+0.23%
as of close, Nov 17, 2026
☾ AH $68.68 +0.23%
Share this page

Royalty Pharma plc trailing returns

How Royalty Pharma plc (RPRX) has performed over the last day, week, month and year, over 5 years, and since inception, through November 17, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

Data provided bySource: Twelve Data

To 2026-11-17. Price return + dividends = total return. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
Cumulative
1 day+0.2%+0.0%+0.2%—
5 days-1.1%+0.3%-0.8%-2.1%Nov 16
1 month+12.7%+0.4%+13.0%-2.1%Nov 16
YTD+77.7%+3.1%+80.8%-12.1%Oct 8
Per year (CAGR)
1 year+75.4%+3.0%+78.4% CAGR-12.1%Oct 2026
5 years+10.1%+2.7%+12.8% CAGR+82.3% total-45.6%Dec 2024
Since 2020+7.0%+2.4%+9.4% CAGR+77.5% total-54.0%Dec 2024

Growth of RPRX#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+12.8%/year · +82.3%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-11-17). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in RPRX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Royalty Pharma plc's return since inception?
Since 2020, Royalty Pharma plc (RPRX) has compounded at about +9.4% a year — +77.5% in total.

More on Royalty Pharma plc